Acute exercise is associated with reduced exhaled nitric oxide in physically inactive adults with asthma

Ann Allergy Asthma Immunol. 2015 Jun;114(6):470-9. doi: 10.1016/j.anai.2015.04.002. Epub 2015 Apr 29.

Abstract

Background: Although exercise has multiple health benefits, relatively little attention has been paid to its potential therapeutic effects in those with asthma.

Objective: To examine the effects of acute exercise on inflammation in physically inactive and active adults with asthma.

Methods: Fourteen adults with asthma (n = 6 physically inactive, n = 8 physically active) completed (1) 30 minutes of moderate-intensity exercise on a treadmill and (2) 30 minutes of rest in random order, with 4 weeks between sessions. Exhaled nitric oxide (eNO) was measured before and after the intervention (0, 0.5, 1, 2, 4, and 24 hours). Blood inflammatory mediators were measured before and after the intervention (0, 2, and 24 hours).

Results: Physically inactive participants had a significant decrease in eNO 4 hours after exercise (-4.8 ppb, -6.4 to -0.5 ppb, P = .028), which was not observed in physically active participants (P = .362). Interluekin-1 receptor antagonist increased in the physically inactive group 2 hours after exercise, with this increase strongly correlated with the decrease in eNO at 4 hours (R = -0.685, P = .007) and 24 hours (R = -0.659, P = .014) after exercise. Interleukin-6 was increased significantly 2 hours after exercise in physically inactive participants. Blood neutrophils and nuclear factor erythroid 2-like 2 gene expression were increased 2 hours after exercise in the overall cohort.

Conclusion: This study demonstrates that acute moderate-intensity exercise is associated with decreased eNO in physically inactive adults with asthma and suggests that interluekin-1 receptor antagonist could have a role in mediating this effect. The attenuated response in physically active participants might be due to the sustained anti-inflammatory effects of exercise training. Future studies should investigate the impact of exercise intensity and exercise training on airway inflammation in those with asthma.

Trial registration: Australian New Zealand Clinical Trials Registry (http://www.anzctr.org.au), registration number ACTRN12613001014741.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents
  • Asthma / metabolism*
  • Asthma / therapy
  • Breath Tests
  • Cytokines / biosynthesis
  • Exercise / physiology*
  • Exhalation
  • Female
  • Humans
  • Inflammation / therapy
  • Inflammation Mediators / blood
  • Interleukin 1 Receptor Antagonist Protein / blood*
  • Interleukin-6 / blood
  • Interleukin-6 / immunology
  • Leukocyte Count
  • Male
  • Middle Aged
  • NF-E2-Related Factor 2 / biosynthesis
  • Neutrophils / immunology
  • Nitric Oxide / metabolism*
  • Pulmonary Elimination
  • Receptors, Interleukin-1 / antagonists & inhibitors
  • Sedentary Behavior
  • Superoxide Dismutase / metabolism
  • Young Adult

Substances

  • Anti-Inflammatory Agents
  • Cytokines
  • IL6 protein, human
  • Inflammation Mediators
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-6
  • NF-E2-Related Factor 2
  • Receptors, Interleukin-1
  • Nitric Oxide
  • Superoxide Dismutase

Associated data

  • ANZCTR/ACTRN12613001014741